✦ LIBER ✦

Cetuximab beneficial for refractory colorectal cancer

Book ID: 120848830
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2006
Weight: 120 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200615630-00031

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cetuximab effective in treatment-refract

Cetuximab effective in treatment-refractory metastatic colorectal cancer

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Cetuximab Monotherapy and Cetuximab plus

Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer

✍ Cunningham, David; Humblet, Yves; Siena, Salvatore; Khayat, David; Bleiberg, Har 📂 Article 📅 2004 🏛 Massachusetts Medical Society 🌐 English ⚖ 129 KB

Cetuximab for metastatic colorectal canc

Cetuximab for metastatic colorectal cancer

✍ Sharan Prakash Sharma 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 246 KB

EGFR FISH assay predicts for response to

EGFR FISH assay predicts for response to cetuximab in chemotherapy refractory colorectal cancer patients

✍ Pressiani, T.; Cappuzzo, F.; Finocchiaro, G.; Rossi, E.; Janne, P.A.; Carnaghi, 📂 Article 📅 2008 🏛 Oxford University Press 🌐 English ⚖ 124 KB

Pharmacogenetic Profiling for Cetuximab

Pharmacogenetic Profiling for Cetuximab Plus Irinotecan Therapy in Patients With Refractory Advanced Colorectal Cancer

✍ Graziano, F.; Ruzzo, A.; Loupakis, F.; Canestrari, E.; Santini, D.; Catalano, V. 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 127 KB

Cetuximab for the Treatment of Colorecta

Cetuximab for the Treatment of Colorectal Cancer

✍ Jonker, Derek J.; O'Callaghan, Chris J.; Karapetis, Christos S.; Zalcberg, John 📂 Article 📅 2007 🏛 Massachusetts Medical Society 🌐 English ⚖ 301 KB